After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.
The Scientist
Most Recent
The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.
Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Breast implants leaking contaminated silicone are causing a fuss in Europe, but all breast implants carry risks.
Page 1 of 1
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
